Related Experiment Video
Updated: Aug 10, 2025

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
G against Glioma: G protein inhibitory α subunit 2 (Gαi2) as a novel glioma target
1Haematology Laboratory-Unit of Molecular Biology, University Hospital of Ioannina, Ioannina, Greece.
Abstract:
Glioma is among the cancers with the highest mortality and morbidity. The complex biology and acquired chemoresistance create a continuous need for novel, effective therapies. In a recent report by Wang et al, an elegant bioinformatic analysis revealed potential functions and underlying chemopreventive mechanisms involving G protein inhibitory α subunit 2 (Gαi2), which activates NF-κB, a master transcription factor in the regulation of glioma. Given that NF-κB takes part in positive regulatory feedback loops during glioma development, Gαi2 is an attractive candidate for targeted therapies. This discovery unlocks new avenues towards understanding the biology of gliomagenesis as well as the discovery of novel targeted antiglioma agents.
Insights
A study identified G protein inhibitory α subunit 2 (Gαi2) as a key factor in glioma development by activating NF-κB. This finding offers new therapeutic targets for combating this deadly brain cancer.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Glioma presents significant mortality and morbidity challenges due to complex biology and chemoresistance.
- Novel therapeutic strategies are urgently needed for effective glioma treatment.
Discussion:
- A bioinformatic analysis by Wang et al. highlighted the role of G protein inhibitory α subunit 2 (Gαi2) in glioma.
- Gαi2 activation of NF-κB is implicated in glioma development and progression.
- NF-κB's involvement in positive regulatory feedback loops underscores Gαi2's potential as a therapeutic target.
Key Insights:
- G protein inhibitory α subunit 2 (Gαi2) is identified as a crucial regulator in glioma.
- The study elucidates the mechanism of Gαi2 activating NF-κB, a key factor in glioma biology.
- Gαi2 presents a promising target for novel antiglioma therapies.
Outlook:
- This research opens new pathways for understanding gliomagenesis.
- The findings facilitate the discovery of targeted antiglioma agents.
- Further investigation into Gαi2-mediated pathways could lead to improved glioma treatments.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Related Concept Videos
Activation and Inactivation of G Proteins
GTPases and their Regulation
Large G-proteins,...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G-Protein Gated Ion Channels
Sensory...
G-protein Coupled Receptors
GPCRs Regulate Adenylyl Cylase Activity